Karyopharm Therapeutics – It's pretty good to be here. | Comparably

Karyopharm Therapeutics – It's pretty good to be here.

Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
Dieses Unternehmen nimmt Feedback von überprüften Mitarbeitern entgegen
MITARBEITER
TEILNEHMER
90
GESAMT
BEWERTUNGEN
2628

It's pretty good to be here.

Was sind einige der besten Dinge an Ihrem Team?

Diverse team with different strengths working collaboratively.

Was ist das Beste an Ihrem Vergütungspaket?

Salary and bonus is consistent with other companies.

Was macht Sie bei der Arbeit am glücklichsten?

It's a challenging work environment where I feel like I'm learning and growing.

Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?

People are clear about the unique expectations they face so we can find solutions.

×
Bewerten Sie Ihr Unternehmen